> top > docs > PMC:7299399 > spans > 31017-31313 > annotations

PMC:7299399 / 31017-31313 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T138 61-74 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T32 61-74 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T284 61-74 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T285 279-280 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T231 123-140 Chemical denotes immunosuppressant http://purl.obolibrary.org/obo/CHEBI_35705
T232 286-290 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T121 0-296 Sentence denotes In addition, specific nanotools can be designed to evade the immune system and to enhance the solubility of poorly soluble immunosuppressant agents; the potential of finely tuning their surface charge opens possibilities for encapsulation strategies and offers accommodation for a high drug load.